• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Low profilin 1 serum levels are associated with diabetes, family history and multivessel lesions in patients with coronary artery disease.

作者信息

Paszek Elżbieta, Zajdel Wojciech, Plens Krzysztof, Żmudka Krzysztof, Legutko Jacek, Kleczyński Paweł

机构信息

Clinical Department of Interventional Cardiology, John Paul II Hospital, Krakow, Poland.

KCRI, Krakow, Poland.

出版信息

Postepy Kardiol Interwencyjnej. 2021 Sep;17(3):305-308. doi: 10.5114/aic.2021.109159. Epub 2021 Sep 14.

DOI:10.5114/aic.2021.109159
PMID:34819967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8596711/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fce/8596711/178e89bb49ac/PWKI-17-45161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fce/8596711/178e89bb49ac/PWKI-17-45161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fce/8596711/178e89bb49ac/PWKI-17-45161-g001.jpg

相似文献

1
Low profilin 1 serum levels are associated with diabetes, family history and multivessel lesions in patients with coronary artery disease.血清中纤连蛋白1水平低与冠心病患者的糖尿病、家族史及多支血管病变相关。
Postepy Kardiol Interwencyjnej. 2021 Sep;17(3):305-308. doi: 10.5114/aic.2021.109159. Epub 2021 Sep 14.
2
Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.糖尿病合并多支冠状动脉疾病患者冠状动脉旁路移植术与药物洗脱支架置入术的比较：一项荟萃分析。
Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):347-54. doi: 10.1093/icvts/ivt509. Epub 2013 Dec 16.
3
The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose.糖尿病或空腹血糖受损的冠心病患者中，对氧磷酶1（PON1）活性、氧化型低密度脂蛋白（oxLDL）水平与冠状动脉病变之间的关系。
Coron Artery Dis. 2008 Dec;19(8):565-73. doi: 10.1097/MCA.0b013e3283109206.
4
Accuracy of peak treadmill exercise echocardiography to detect multivessel coronary artery disease: comparison with post-exercise echocardiography.平板运动高峰超声心动图检测多支冠状动脉疾病的准确性：与运动后超声心动图的比较。
Eur J Echocardiogr. 2003 Sep;4(3):182-90. doi: 10.1016/s1525-2167(02)00168-3.
5
Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease.依维莫司洗脱支架与冠状动脉旁路移植术治疗糖尿病合并多支血管病变患者的疗效比较
Circ Cardiovasc Interv. 2015 Jul;8(7):e002626. doi: 10.1161/CIRCINTERVENTIONS.115.002626.
6
Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease.个体化多血管病变糖尿病患者的血运重建策略。
J Am Coll Cardiol. 2019 Oct 22;74(16):2074-2084. doi: 10.1016/j.jacc.2019.07.083.
7
[Correlation of microalbuminuria and fibrinogen to the severity of coronary artery lesions in patients with metabolic syndrome].
Nan Fang Yi Ke Da Xue Xue Bao. 2010 Nov;30(11):2459-62.
8
Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial.多支冠状动脉疾病对 ST 段抬高型心肌梗死患者再灌注成功的影响：AIDA STEMI 试验的一个亚研究。
Eur Heart J Acute Cardiovasc Care. 2017 Oct;6(7):592-600. doi: 10.1177/2048872615624240. Epub 2015 Dec 21.
9
The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study：5 年随访：多血管病变糖尿病患者经皮冠状动脉介入治疗与冠状动脉旁路移植术血运重建的比较。
J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):26-33. doi: 10.2459/JCM.0b013e328330ea32.
10
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.多部位、多血管病变患者中应用依维莫司洗脱支架和紫杉醇洗脱支架的对比：SPIRIT III 试验（在治疗初发冠状动脉病变患者中对依维莫司洗脱冠状动脉支架系统（EECSS）的 XIENCE V 血管内介入器械的临床评估）和 SPIRIT IV 试验（在治疗初发冠状动脉病变患者中对依维莫司洗脱冠状动脉支架系统的 XIENCE V 血管内介入器械的临床评估）随机临床试验。
JACC Cardiovasc Interv. 2010 Dec;3(12):1229-39. doi: 10.1016/j.jcin.2010.09.014.

引用本文的文献

1
Significance of fragmented QRS and predictors of outcome in ST-elevation myocardial infarction.ST段抬高型心肌梗死中碎裂QRS的意义及预后预测因素
J Res Med Sci. 2024 Apr 29;29:23. doi: 10.4103/jrms.jrms_68_23. eCollection 2024.
2
Proteomic Signatures of the Serological Response to Influenza Vaccination in a Large Human Cohort Study.在一项大型人类队列研究中，流感疫苗接种后血清反应的蛋白质组学特征。
Viruses. 2022 Nov 9;14(11):2479. doi: 10.3390/v14112479.
3
Profilin 1 and Mitochondria-Partners in the Pathogenesis of Coronary Artery Disease?

本文引用的文献

1
The role of profilin-1 in cardiovascular diseases.原肌球蛋白-1 在心血管疾病中的作用。
J Cell Sci. 2021 May 1;134(9). doi: 10.1242/jcs.249060. Epub 2021 May 7.
2
Profilin 1 and Mitochondria-Partners in the Pathogenesis of Coronary Artery Disease?肌动蛋白结合蛋白 1 与线粒体——冠心病发病机制中的伙伴？
Int J Mol Sci. 2021 Jan 22;22(3):1100. doi: 10.3390/ijms22031100.
3
Actin remodelling of the endothelium during transendothelial migration of leukocytes.白细胞穿越内皮细胞时内皮细胞的肌动蛋白重塑。
肌动蛋白结合蛋白 1 与线粒体——冠心病发病机制中的伙伴？
Int J Mol Sci. 2021 Jan 22;22(3):1100. doi: 10.3390/ijms22031100.
Atherosclerosis. 2020 Dec;315:102-110. doi: 10.1016/j.atherosclerosis.2020.06.004. Epub 2020 Jul 5.
4
Evaluation of profilin 1 as a biomarker in myocardial infarction.评价原肌球蛋白 1 作为心肌梗死的生物标志物。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8112-8116. doi: 10.26355/eurrev_202008_22497.
5
5. Prevention or Delay of Type 2 Diabetes: .5. 2 型糖尿病的预防或延迟： 。
Diabetes Care. 2018 Jan;41(Suppl 1):S51-S54. doi: 10.2337/dc18-S005.
6
Role of protein carbonylation in diabetes.蛋白质羰基化在糖尿病中的作用。
J Inherit Metab Dis. 2018 Jan;41(1):29-38. doi: 10.1007/s10545-017-0104-9. Epub 2017 Nov 6.
7
Profilin1 biology and its mutation, actin(g) in disease.丝切蛋白1的生物学特性及其突变与疾病中的肌动蛋白（g）
Cell Mol Life Sci. 2017 Mar;74(6):967-981. doi: 10.1007/s00018-016-2372-1. Epub 2016 Sep 26.
8
Mutations of Profilin-1 Associated with Amyotrophic Lateral Sclerosis Promote Aggregation Due to Structural Changes of Its Native State.与肌萎缩侧索硬化症相关的丝切蛋白-1突变因其天然状态的结构变化而促进聚集。
ACS Chem Biol. 2015 Nov 20;10(11):2553-63. doi: 10.1021/acschembio.5b00598. Epub 2015 Aug 27.
9
Structural basis for mutation-induced destabilization of profilin 1 in ALS.肌萎缩侧索硬化症中突变诱导的丝切蛋白1不稳定的结构基础。
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):7984-9. doi: 10.1073/pnas.1424108112. Epub 2015 Jun 8.
10
Changes in thrombus composition and profilin-1 release in acute myocardial infarction.急性心肌梗死中血栓成分和前细丝蛋白-1 的释放变化。
Eur Heart J. 2015 Apr 21;36(16):965-75. doi: 10.1093/eurheartj/ehu356. Epub 2014 Sep 12.